BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

BRL 17421 is a new semisynthetic beta-lactam antibiotic with an unusual spectrum of antibacterial activity. The compound exhibits exceptional stability to a wide range of bacterial beta-lactamases and is active against the majority of Enterobacteriaceae, including strains highly resistant to many of...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Slocombe, B, Basker, M J, Bentley, P H, Clayton, J P, Cole, M, Comber, K R, Dixon, R A, Edmondson, R A, Jackson, D, Merrikin, D J, Sutherland, R
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 1981
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181629/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6974539/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.1.38
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!